EP0322033A3

New 2,5-diaryl tetrahydrofurans and analogs thereof as paf antagonists

Abstract

A class of 2,5-diaryl tetrahydrofuran derivatives are PAF antagonists and are therefore useful in the treatment of various diseases including prevention of platelet aggregation, hypotension, inflammation, asthma, lung edema, adult respiratory distress syndrome, various shock syndromes, cardiovascular disorders and other related skeletal-muscular disorders.

Term

Term ended

Projected expiry passed 14 December 2008, 17.8 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

Every citation, both ways

Citations
DocumentRelationOfficeCategoryCited during
EP0144804A2CitesEuropean Patent Office (EPO)XSearch report
EP0199324A2CitesEuropean Patent Office (EPO)XSearch report
US3769350ACitesUnited States of AmericaXSearch report
US4595693ACitesUnited States of AmericaXSearch report